Literature DB >> 2730100

Natural killer cell activity is reduced in patients with severe forms of inherited epidermolysis bullosa.

S K Tyring1, V Chopra, L Johnson, J D Fine.   

Abstract

Natural killer (NK) cell activity was evaluated in 34 patients with inherited forms of epidermolysis bullosa (EB). While the NK activity of EB simplex patients did not differ from that of control subjects, persons with more severe forms of EB demonstrated significant reductions in NK activity. The degree of this reduction was directly related to the severity of the skin involvement by EB with recessive dystrophic EB patients having the lowest NK activity. The absolute number of cells bearing NK surface markers in the peripheral blood of patients with recessive dystrophic EB did not differ from that of normal control subjects. This reduced NK activity may be at least partially responsible for the occurrence of septicemia in some persons with severe forms of EB and for the development of metastatic squamous cell carcinoma in patients with dystrophic EB.

Entities:  

Mesh:

Year:  1989        PMID: 2730100

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  3 in total

1.  Patients with severe forms of inherited epidermolysis bullosa exhibit decreased lymphokine and monokine production.

Authors:  V Chopra; S K Tyring; L Johnson; J D Fine
Journal:  J Clin Immunol       Date:  1990-11       Impact factor: 8.317

Review 2.  Epidermolysis bullosa: Advances in research and treatment.

Authors:  Christine Prodinger; Julia Reichelt; Johann W Bauer; Martin Laimer
Journal:  Exp Dermatol       Date:  2019-08-08       Impact factor: 3.960

3.  Cells from discarded dressings differentiate chronic from acute wounds in patients with Epidermolysis Bullosa.

Authors:  Ignacia Fuentes; Christina Guttmann-Gruber; Birgit Tockner; Anja Diem; Alfred Klausegger; Glenda Cofré-Araneda; Olga Figuera; Yessia Hidalgo; Pilar Morandé; Francis Palisson; Boris Rebolledo-Jaramillo; María Joao Yubero; Raymond J Cho; Heather I Rishel; M Peter Marinkovich; Joyce M C Teng; Timothy G Webster; Marco Prisco; Luis H Eraso; Josefina Piñon Hofbauer; Andrew P South
Journal:  Sci Rep       Date:  2020-09-15       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.